Simple view
Full metadata view
Authors
Statistics
Activity of cabozantinib in further line treatment of metastatic clear cell renal cell carcinoma. Real-world experience in a single-center retrospective study
Journal
Współczesna Onkologia-Contemporary Oncology
70
Author
Volume
27
Number
3
Pages
190-197
ISSN
1428-2526
eISSN
1897-4309
Keywords in English
second-line treatment
tyrosine-kinase inhibitors (TKI)
metastatic renal cell carcinoma (mRCC)
cabozantinib
further line treatment
Access date
2023-12-27
Language
English
Journal language
English
Affiliation
Wydział Farmaceutyczny : Zakład Diagnostyki Medycznej
Scopus© citations
2
| dc.affiliation | Wydział Farmaceutyczny : Zakład Diagnostyki Medycznej | pl |
| dc.cm.date | 2023-12-27T23:19:10Z | |
| dc.cm.id | 114061 | pl |
| dc.cm.idOmega | UJCM4758c83b68ae40378196cfe0d66f42fe | pl |
| dc.contributor.author | Domański, Piotr | pl |
| dc.contributor.author | Jarosińska, Jadwiga | pl |
| dc.contributor.author | Kruczyk, Barbara | pl |
| dc.contributor.author | Piętak, Mateusz | pl |
| dc.contributor.author | Mydlak, Anna | pl |
| dc.contributor.author | Demkow, Tomasz | pl |
| dc.contributor.author | Kuncman, Łukasz | pl |
| dc.contributor.author | Darewicz, Marta | pl |
| dc.contributor.author | Sikora-Kupis, Bożena | pl |
| dc.contributor.author | Dumnicka, Paulina - 186623 | pl |
| dc.contributor.author | Kucharz, Jakub | pl |
| dc.date.accession | 2023-12-27 | pl |
| dc.date.accessioned | 2023-12-27T23:19:10Z | |
| dc.date.available | 2023-12-27T23:19:10Z | |
| dc.date.issued | 2023 | pl |
| dc.date.openaccess | 0 | |
| dc.description.accesstime | w momencie opublikowania | |
| dc.description.number | 3 | pl |
| dc.description.physical | 190-197 | pl |
| dc.description.version | ostateczna wersja wydawcy | |
| dc.description.volume | 27 | pl |
| dc.identifier.doi | 10.5114/wo.2023.133545 | pl |
| dc.identifier.eissn | 1897-4309 | pl |
| dc.identifier.issn | 1428-2526 | pl |
| dc.identifier.uri | https://ruj.uj.edu.pl/xmlui/handle/item/324811 | |
| dc.identifier.weblink | https://www.termedia.pl/Activity-of-cabozantinib-in-further-line-treatment-of-metastatic-clear-cell-renal-cell-carcinoma-Real-world-experience-in-a-single-center-retrospective-study,3,51998,0,1.html | pl |
| dc.language | eng | pl |
| dc.language.container | eng | pl |
| dc.pbn.affiliation | Dziedzina nauk medycznych i nauk o zdrowiu : nauki medyczne | |
| dc.rights | Udzielam licencji. Uznanie autorstwa - Użycie niekomercyjne - Na tych samych warunkach 4.0 Międzynarodowa | |
| dc.rights.licence | CC-BY-NC-SA | |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/4.0/legalcode.pl | |
| dc.share.type | Otwarte czasopismo | |
| dc.subject.en | second-line treatment | |
| dc.subject.en | tyrosine-kinase inhibitors (TKI) | |
| dc.subject.en | metastatic renal cell carcinoma (mRCC) | |
| dc.subject.en | cabozantinib | |
| dc.subject.en | further line treatment | |
| dc.subtype | Article | pl |
| dc.title | Activity of cabozantinib in further line treatment of metastatic clear cell renal cell carcinoma. Real-world experience in a single-center retrospective study | pl |
| dc.title.journal | Współczesna Onkologia-Contemporary Oncology | pl |
| dc.type | JournalArticle | pl |
| dspace.entity.type | Publication |
dc.affiliationpl
Wydział Farmaceutyczny : Zakład Diagnostyki Medycznej dc.cm.date
2023-12-27T23:19:10Z dc.cm.idpl
114061 dc.cm.idOmegapl
UJCM4758c83b68ae40378196cfe0d66f42fe dc.contributor.authorpl
Domański, Piotr dc.contributor.authorpl
Jarosińska, Jadwiga dc.contributor.authorpl
Kruczyk, Barbara dc.contributor.authorpl
Piętak, Mateusz dc.contributor.authorpl
Mydlak, Anna dc.contributor.authorpl
Demkow, Tomasz dc.contributor.authorpl
Kuncman, Łukasz dc.contributor.authorpl
Darewicz, Marta dc.contributor.authorpl
Sikora-Kupis, Bożena dc.contributor.authorpl
Dumnicka, Paulina - 186623 dc.contributor.authorpl
Kucharz, Jakub dc.date.accessionpl
2023-12-27 dc.date.accessioned
2023-12-27T23:19:10Z dc.date.available
2023-12-27T23:19:10Z dc.date.issuedpl
2023 dc.date.openaccess
0 dc.description.accesstime
w momencie opublikowania dc.description.numberpl
3 dc.description.physicalpl
190-197 dc.description.version
ostateczna wersja wydawcy dc.description.volumepl
27 dc.identifier.doipl
10.5114/wo.2023.133545 dc.identifier.eissnpl
1897-4309 dc.identifier.issnpl
1428-2526 dc.identifier.uri
https://ruj.uj.edu.pl/xmlui/handle/item/324811 dc.identifier.weblinkpl
https://www.termedia.pl/Activity-of-cabozantinib-in-further-line-treatment-of-metastatic-clear-cell-renal-cell-carcinoma-Real-world-experience-in-a-single-center-retrospective-study,3,51998,0,1.html dc.languagepl
eng dc.language.containerpl
eng dc.pbn.affiliation
Dziedzina nauk medycznych i nauk o zdrowiu : nauki medyczne dc.rights
Udzielam licencji. Uznanie autorstwa - Użycie niekomercyjne - Na tych samych warunkach 4.0 Międzynarodowa dc.rights.licence
CC-BY-NC-SA dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/4.0/legalcode.pl dc.share.type
Otwarte czasopismo dc.subject.en
second-line treatment dc.subject.en
tyrosine-kinase inhibitors (TKI) dc.subject.en
metastatic renal cell carcinoma (mRCC) dc.subject.en
cabozantinib dc.subject.en
further line treatment dc.subtypepl
Article dc.titlepl
Activity of cabozantinib in further line treatment of metastatic clear cell renal cell carcinoma. Real-world experience in a single-center retrospective study dc.title.journalpl
Współczesna Onkologia-Contemporary Oncology dc.typepl
JournalArticle dspace.entity.type
Publication Affiliations
Wydział Farmaceutyczny
Dumnicka, Paulina
No affiliation
Domański, Piotr
Jarosińska, Jadwiga
Kruczyk, Barbara
Piętak, Mateusz
Mydlak, Anna
Demkow, Tomasz
Kuncman, Łukasz
Darewicz, Marta
Sikora-Kupis, Bożena
Kucharz, Jakub
* The migration of download and view statistics prior to the date of April 8, 2024 is in progress.
Views
8
Views per month
Views per city
Ashburn
2
Downloads
dumnicka_et-al_activity_of_cabozantinib_2023.pdf
2
Open Access
No Thumbnail Available
